Alison Y. Zhang

The University of Sydney — Australia

Medicine · Health Sciences

20h-index5.2kcitations49works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(19), Cancer, Lipids, and Metabolism(14), Radiopharmaceutical Chemistry and Applications(13), Fatty Acid Research and Health(4), Metabolomics and Mass Spectrometry Studies(4)

Publications47 total

181P Phase II trial of first-line durvalumab and chemotherapy in patients with extra-pulmonary small cell carcinoma
Annals of Oncology·2025
Effect of Rumen-Protected Lysine Supplementation on Growth Performance, Blood Metabolites, Rumen Fermentation and Bacterial Community on Feedlot Yaks Offered Corn-Based Diets
Animals·2025· 1 citedOpen Access
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
BJUI Compass·2025Open Access
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial
The Lancet Oncology·2025· 12 cited
survregVB: Variational Bayesian Analysis of Survival Data
2025Open Access
Characterization of volatile flavour compounds and characteristic flavour precursors in poultry eggs based on multi-omics and machine learning
Food Chemistry·2025· 12 cited
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial
Nature Medicine·2025· 18 cited
[Tornwaldt cysts in a child: a case report].
PubMed·2025
Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
Future Oncology·2025· 1 citedOpen Access
Pembrolizumab and Denosumab in clear-cell renal-cell carcinoma
SSRN Electronic Journal·2025Open Access
Metabolic Characteristics and Biomarker Screening of Poultry Eggs from Different Species
SSRN Electronic Journal·2025Open Access
[ALK-positive histiocytosis of nasal vestibule: one case report].
PubMed·2024
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
European Urology Oncology·2023· 18 cited
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
The Lancet Oncology·2023· 177 citedOpen Access
Data from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer
2023Open Access
Data from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer
2023Open Access
Supplementary Figures 1-3 from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer
2023Open Access
Supplementary Figures 1-3 from Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer
2023Open Access
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
The Lancet Oncology·2023· 175 cited
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial
The Lancet Oncology·2022· 240 cited
page 1 of 3Next →

Frequent Co-authors

Martin R. Stockler(25), Ian D. Davis(22), Anthony M. Joshua(22), Lisa G. Horvath(19), Andrew Martin(16), Shahneen Sandhu(16), Margaret McJannett(14), Thean Hsiang Tan(12), Scott Williams(11), Michael S. Hofman(11), Louise Emmett(11), Roslyn J. Francis(11), Arun Azad(11), Andrew Weickhardt(10), Gavin Marx(9), Siobhan Ng(9), Hui‐Ming Lin(9), Lisa M. Butler(9), Nicola Jane Lawrence(8), David Pook(8)